European urology focus最新文献

{"title":"A Comparative Review of Contemporary Urological Trauma Guidelines.","authors":"John Myrga, Behzad Abbasi, Benjamin N Breyer","doi":"10.1016/j.euf.2026.04.013","DOIUrl":"https://doi.org/10.1016/j.euf.2026.04.013","url":null,"abstract":"<p><strong>Background and objective: </strong>Urologic trauma management has evolved toward standardized, guideline-based care. The American Urological Association (AUA) and European Association of Urology (EAU) have independently created specialty-specific recommendations based on existing literature. This study aims to compare the most recent iterations of AUA and EAU urologic trauma guidelines, focusing on similarities and differences across key injury domains.</p><p><strong>Methods: </strong>A narrative comparative review was conducted of the latest AUA (updated through 2020) and EAU (updated in 2025) guidelines. Recommendations were analyzed across renal, ureteral, bladder, urethral, and genital trauma, with attention to diagnostic strategies, management approaches, and follow-up protocols.</p><p><strong>Key findings and limitations: </strong>Both guidelines emphasize conservative management for hemodynamically stable patients and share similar frameworks across trauma types. In renal trauma, both recommend contrast-enhanced imaging and nonoperative management, though AUA allows intervention based on hematoma size, while EAU prioritizes angioembolization. EAU uniquely recommends structured follow-up, including imaging and blood pressure monitoring. In ureteral trauma, AUA provides more specific diagnostic protocols, while EAU emphasizes prevention of iatrogenic injury. Bladder and urethral trauma recommendations are broadly aligned, though EAU includes more detailed guidance on iatrogenic injuries and post-treatment imaging. Limitations include reliance on expert opinion due to limited high-quality evidence and lack of incorporation of recent radiologic grading system updates.</p><p><strong>Conclusions and clinical implications: </strong>AUA and EAU guidelines largely converge on conservative, patient-centered management but differ in specificity and emphasis. EAU prioritizes prevention and follow-up, while AUA provides more detailed procedural guidance. Understanding these distinctions can inform clinical decision-making and highlight areas for future evidence development.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147856151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Algorithmic Approach to the Management of Patients with Adult-acquired Buried Penis Syndrome.","authors":"Roger D Klein, Folawiyo Laditi, Paul J Rusilko","doi":"10.1016/j.euf.2026.04.012","DOIUrl":"https://doi.org/10.1016/j.euf.2026.04.012","url":null,"abstract":"<p><p>Adult-acquired buried penis (AABP) syndrome arises when the phallus becomes buried in the peripubic skin and soft tissues, leading to a cycle of urine trapping, superficial infections, and chronic inflammation. Conservative management with weight loss and topical steroids alone are often insufficient to halt or reverse the detrimental medical and psychosocial effects of AABP. An awareness of common comorbidities, including urethral stricture disease, lichen sclerosus, and penile cancer, is crucial for diagnosis and management of this syndrome. Multiple studies have demonstrated an improvement in adverse medical and psychosocial outcomes with appropriate surgical management. Here, we present an overview of the diagnosis and management of AABP and propose a management algorithm focused on symptomatology, physical examination findings, and the presence of concurrent pathology.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147835766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reply to Singh and Srivastav's Letter to the Editor re: Amy Lockefeer, Arianne Schild, Swapneel Anaokar, et al. Efficacy and Safety of Mirabegron in Patients with Overactive Bladder and Cardiovascular Comorbidities: A Post Hoc Analysis of Randomised Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2026.01.010.","authors":"Amy Lockefeer, Arianne Schild, Swapneel Anaokar, Mikkel Fode","doi":"10.1016/j.euf.2026.04.011","DOIUrl":"https://doi.org/10.1016/j.euf.2026.04.011","url":null,"abstract":"","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147835793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Podcasting in Urological Education - 200 Episodes and 200 000 Downloads: The Expanding Educational Impact and Global Reach of the European Association of Urology-European School of Urology (EAU-ESU) Podcast.","authors":"Bhaskar K Somani, Nan Li, Jurgita Liumaite, Benjamin Pradere, Fardod O'Kelly, Jacobijn Sedelaar-Maaskant, Evangelos Liatsikos","doi":"10.1016/j.euf.2026.04.010","DOIUrl":"https://doi.org/10.1016/j.euf.2026.04.010","url":null,"abstract":"<p><p>The European Association of Urology podcast programme has shown substantial global growth and reach, establishing it as an effective and accessible tool for modern urological education. The rapid dissemination of expert knowledge and integrated multidisciplinary perspectives positions podcasting as a key driver of future digital learning, collaboration, and equitable knowledge sharing worldwide.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147812614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"\"Pro/ 'Yes' for PSA Testing Before BPO Surgical Therapy\" Ignoring PSA in BPE is Not Progress; It's Clinical Blindness.","authors":"Selcuk Guven, Thomas Rw Herrmann","doi":"10.1016/j.euf.2026.04.006","DOIUrl":"https://doi.org/10.1016/j.euf.2026.04.006","url":null,"abstract":"<p><p>Although traditionally linked to prostate cancer screening, prostate-specific antigen (PSA) serves as a multifaceted clinical marker in men with lower urinary tract symptoms. PSA reflects prostate biology, predicts disease progression, and guides treatment decisions in benign prostatic enlargement. As a dynamic biomarker, changes in PSA over time indicate treatment response and disease course. PSA also facilitates oncological assessment, as enucleation reduces benign glandular interference and establishes a more reliable baseline for detecting incidental or future malignancy. Consequently, the clarity of PSA interpretation depends on the treatment approach, with complete adenoma removal yielding a more distinct clinical signal than tissue-ablative methods. PSA should be considered a continuous biomarker throughout the care pathway.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147812643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"AI-driven Predictive Models in Endourological Treatment of Urolithiasis: A Systematic Review of Nomogram Applications from EAU Endourology.","authors":"Natali Rodriguez Peñaranda, Frédéric Panthier, Stefano Di Bari, Nicolò Lugli, Marco Ticonosco, Antonio Botto, Francesco Di Bello, Maria Chiara Sighinolfi, Tommaso Calcagnile, Rosario Leonardi, Bhaskar Somani, Olivier Traxer, Salvatore Micali","doi":"10.1016/j.euf.2026.04.004","DOIUrl":"https://doi.org/10.1016/j.euf.2026.04.004","url":null,"abstract":"<p><strong>Background: </strong>Artificial intelligence (AI) is increasingly applied in endourology to enhance surgical planning, risk stratification, and outcome prediction. This systematic review evaluates AI-labelled prediction models predicting treatment-related outcomes in patients with urinary stone disease undergoing endourological procedures.</p><p><strong>Methods: </strong>A systematic search of PubMed, EMBASE, Scopus, and Web of Science was conducted up to May 2025, following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Original studies assessing AI-labelled prediction models for clinical outcomes after ureteroscopy, retrograde intrarenal surgery, or percutaneous nephrolithotomy were included. Data were extracted on modelling approach, outcomes, prevalence, and reporting of discrimination, calibration, and clinical utility, as well as the validation strategy. The protocol was registered in PROSPERO (CRD420251090820).</p><p><strong>Results: </strong>Twenty-five studies were included, mostly retrospective and from Asian or European centres. Stone-free rate was the most frequent outcome. Infectious outcomes included febrile urinary tract infection, systemic inflammatory response syndrome, sepsis, fungal infection, and pyonephrosis, while other outcomes comprised operative time, radiation exposure, impacted stones, stone composition, transfusion, stenting, and broader perioperative outcomes. Across outcomes, discrimination was commonly reported, whereas calibration and formal assessment of clinical utility were less consistently reported; validation was predominantly internal, with limited external or temporal validation. One study reported a web-based implementation.</p><p><strong>Conclusions: </strong>AI-labelled prediction models have been developed for multiple clinically relevant outcomes in urinary stone surgery. However, calibration, clinical utility, and robust validation remain inconsistently reported. Future work should prioritise transparent reporting of these elements, alongside multicentre external or temporal validation and more standardised outcome definitions, before routine clinical adoption.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147766705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From FIRST-CARE to RUSTIC Practice: How ROBUST Is the Evidence for Drug-coated Balloon Dilation in Urethral Strictures? A 2026 Clinical Trial Update.","authors":"Navid Roessler, Jakob Klemm, Malte W Vetterlein","doi":"10.1016/j.euf.2026.04.009","DOIUrl":"https://doi.org/10.1016/j.euf.2026.04.009","url":null,"abstract":"<p><p>Drug-coated balloon dilation with Optilume® demonstrates durable functional improvement and high freedom from repeat intervention in recurrent anterior urethral strictures. Ongoing trials, including BALDIKA, FIRST-CARE, and RUSTIC, will further define its role across diverse patient populations.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147766702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Smart Screening in Prostate Cancer: What We Have Learned So Far from PROBASE.","authors":"Rouvier Al-Monajjed, Agne Krilaviciute, Peter Albers","doi":"10.1016/j.euf.2026.04.008","DOIUrl":"https://doi.org/10.1016/j.euf.2026.04.008","url":null,"abstract":"<p><p>Smart prostate cancer screening means screening better: risk stratification, prostate-specific antigen confirmation, expert magnetic resonance imaging, and prostate-specific antigen density-guided biopsy reduce harm without compromising detection of significant disease.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147766681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Twenty-five Years of Panurethral Stricture Repair Using the Kulkarni Technique.","authors":"Sanjay B Kulkarni, Wattanachai Ratanapornsompong, Saurabh Thakkar, Shreyas Bhadranavar, Pankaj M Joshi","doi":"10.1016/j.euf.2026.04.007","DOIUrl":"https://doi.org/10.1016/j.euf.2026.04.007","url":null,"abstract":"<p><p>Panurethral stricture disease represents one of the most challenging conditions in reconstructive urology. Over the past 25 yr, surgical management has evolved from staged skin substitution to single-stage panurethroplasty. The introduction of dorsal buccal mucosal graft urethroplasty and its refinement into the one-sided dissection technique established a reproducible strategy with durable long-term success rates of 80-85% in large series. Limitations of oral graft length and donor-site morbidity have led to further innovation, including the spiral preputial graft, which enables continuous long-segment reconstruction in selected patients. Contemporary multicenter data support acceptable intermediate-term outcomes, although careful patient selection remains essential. PATIENT SUMMARY: Long urethral strictures can now often be repaired in one operation using tissue grafts. These modern techniques provide good long-term results when performed in specialized centers.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147766717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Passive Versus Active Devices for Male Stress Urinary Incontinence: The Case for Passive Devices.","authors":"Vincent Hou, Helen Sun, Brian J Flynn","doi":"10.1016/j.euf.2026.03.012","DOIUrl":"https://doi.org/10.1016/j.euf.2026.03.012","url":null,"abstract":"<p><p>Passive continence devices provide continence outcomes with 30-80% improvement or cure rates while avoiding the cognitive and manual dexterity demands of most active devices. Their patient-independent function and outpatient adjustability align with preferences for simplicity and fewer future interventions.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":5.6,"publicationDate":"2026-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147766711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}